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B I O E N G I N E E R I N G
Epitope-imprinted polymers: Design principles 
of synthetic binding partners for 
natural biomacromolecules
Simão P. B. Teixeira1,2, Rui L. Reis1,2, Nicholas A. Peppas3,4,5,6,7,8*,  
Manuela E. Gomes1,2*, Rui M. A. Domingues1,2*
Molecular imprinting (MI) has been explored as an increasingly viable tool for molecular recognition in various 
fields. However, imprinting of biologically relevant molecules like proteins is severely hampered by several problems. 
Inspired by natural antibodies, the use of epitopes as imprinting templates has been explored to circumvent 
those limitations, offering lower costs and greater versatility. Here, we review the latest innovations in this tech-
nology, as well as different applications where MI polymers (MIPs) have been used to target biomolecules of interest. 
We discuss the several steps in MI, from the choice of epitope and functional monomers to the different production 
methods and possible applications. We also critically explore how MIP performance can be assessed by various 
parameters. Last, we present perspectives on future breakthroughs and advances, offering insights into how MI 
techniques can be expanded to new fields such as tissue engineering.
INTRODUCTION
Molecular recognition is an essential mechanism in a variety of settings 
(1, 2). In the biomedical field, antibodies are fundamental tools owing 
to their high affinity and selectivity toward targeted biomolecules of 
interest. As such, they have been applied for multiple purposes, from 
laboratory immunoassays [enzyme-linked immunosorbent assay 
(ELISA), immunocyto/histochemistry, and Western blot] (3) to tar-
geted therapeutics for neurodegenerative diseases (4) or cancer (5). 
Yet, their expensive cell culture–based production processes, high 
lability, and possible immunogenic risk make them less than ideal (6–8). 
This has led to increased research on alternative binding partners capa-
ble of specific recognition, such as peptides or oligonucleotides (9, 10). 
However, their biological nature similarly raises stability concerns. 
Furthermore, their discovery and production processes are long and 
possibly inefficient, sometimes leading to molecules with limited selec-
tivity and affinity (11, 12). Therefore, the development of selective, sta-
ble, scalable, and cost-effective alternatives is highly sought (13). To 
that end, purely synthetic receptors with abiotic affinity for biomole-
cules based on molecular imprinting (MI) have been proposed for 
numerous biological applications during the last few decades (14–16).
What is molecular imprinting?
MI refers to the creation of specific recognition sites in polymer net-
works by cross-linking in the presence of a template molecule, 
which represents the target to be recognized (17, 18). This process is 
performed by mixing a solution of one (or several) monomer(s) 
with the template, thereby forming temporary interactions between 
the two. Subsequent cross-linking and polymerization, followed by 
removal of the template, lead to the formation of a polymer struc-
ture with embedded complementary cavities for the superstructure 
of the imprinted molecule. These nanocavities preserve not only the 
shape and size but also the molecular interactions necessary for the 
recognition of the target. The resulting molecularly imprinted polymers 
(MIPs) are thus able to selectively recognize and bind the target via 
a “lock and key” mechanism similar to those found in biological 
systems (e.g., antibodies and enzymes).
These biomimetic polymeric networks can be prepared by de-
signing interactions between the building blocks of a biocompatible 
network and the desired specific ligand and stabilizing these inter-
actions by a three-dimensional (3D) structure. These structures are 
at the same time flexible enough to allow for diffusion of solvent 
and ligand into and out of the network. Synthetic networks that can 
be designed to recognize and bind biologically relevant molecules 
are of great importance and influence a number of emerging tech-
nologies (13). These artificial materials can be used either as unique 
systems or incorporated into existing technologies that can aid in 
the removal or delivery of biomolecules, so that the natural profiles 
of compounds in the body can be restored (19, 20).
Such developments are expected to have a major impact on 
diseases, such as diabetes and atherosclerosis, which are caused 
by increased levels of certain compounds in the blood. The moni-
toring and “on-demand” removal of such detrimental compounds 
by polymeric systems are highly desirable, and these can be achieved 
by biomimetic networks (21).
The most important problems to be solved in the design of syn-
thetic recognition-based networks are the following:
1) to obtain reproducible interactions between ligand molecule 
and network, and an ability to differentiate between the ligand and 
similar compounds;
2) to create a network compatible with aqueous solutions;
3) to reduce diffusional limitations of ligand into the bulk net-
work; and
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4) to establish a platform by which recognition-based polymers 
can be used as biomimetic systems.
Several inherent advantages have rendered MIPs an object of 
increasing interest. More than two-thirds of the papers on the sub-
ject of MI have been published over the 2010s alone, according to 
MIPdatabase.com (22) (unfortunately, this database, which consti-
tuted a good repository of MIP literature, has not been updated 
since early 2019). Among the subjects discussed are their affinity 
and selectivity, allowing them to compete with natural biomole-
cules like antibodies (14); greater stability over time and in different 
environments, which allows not only their application in a wider 
range of conditions unsuitable for biomolecules but also their pro-
longed storage without refrigeration (23); and comparatively sim-
pler, faster, and cheaper production methods, making them more 
easily available (24). Another attractive comparative advantage is 
the possibility of developing receptors for molecules with unknown 
natural binding partners and even unexplored structures (12, 25). 
This set of features has led to a growing use of MIPs for purposes 
such as biosensing (15), separation technology (26), food and envi-
ronmental decontamination (27), or targeted drug delivery (28).
What are the challenges of imprinting large 
biomacromolecules?
Creation of wholly synthetic systems capable of recognizing and 
binding proteins would have significant impact and may lead to the 
production of sensors, media for affinity chromatography, detoxi-
fying agents, or as biomaterials with molecularly tailored surfaces 
(29). However, while imprinting small molecules has become stan-
dard practice, targeting macromolecules (such as proteins or poly-
saccharides) has proven more challenging. Proteins have proven 
exceedingly difficult to imprint, despite the great number of surface- 
exposed functionalities. The main limitations associated with im-
printing biological macromolecules have been thoroughly discussed 
by Culver and Peppas (16) and Li et al. (30).
Several fundamental differences between these two different types 
of molecules synergistically contribute to render the initially pro-
posed MI strategies inefficient in the development of synthetic bind-
ing partners for large targets. For instance, biological macromolecules 
exist mostly in highly hydrated environments, such as the cytosol, the 
extracellular matrix, or the blood and lymph streams, being opti-
mized to function in a strict physiological range of conditions (tem-
perature, pH, ionic strength, etc.). On the contrary, most of the 
initially proposed MI protocols used organic solvents, in which pro-
teins are generally insoluble or unstable (30, 31). Besides, these pro-
tocols required operation in extreme polymerization conditions that 
led to denaturation of the template. This meant that cavities formed 
in MIPs did not correspond to the native structure of the template, 
either in shape or in spatial organization of functional groups.
In the first notable example of protein imprinting, Hjertén and co-
workers (32, 33) exploited protocols based on water-soluble monomers 
for applications in the field of affinity separation of proteins. These 
methods used (meth)acrylates and (meth)acrylamides and took place 
in mild aqueous conditions compatible with protein native structures. 
The resulting desirable MIPs are then behaving as hydrogels, exhibit-
ing the corresponding swelling behavior (16, 34). One of the major 
problems identified in these systems is the low diffusivity of macro-
molecules through bulk polymer networks, due to their large size (35).
As discussed further ahead, earlier imprinting methods resulted 
in the formation of binding sites distributed throughout the bulk of 
the material. To retain effective binding sites, densely cross-linked 
materials need to be produced. Thus, mesh sizes are often smaller 
than protein diameters, which greatly hinders rebinding, since pro-
tein access to imprinted sites in the polymer bulk is very difficult. 
Moreover, the same problem affects the removal of the template 
after polymerization. This leads to a need for harsh washing condi-
tions to achieve high efficiency, possibly compromising the quality 
of imprinted sites during this process (30).
This limitation has been, to a certain extent, mitigated with the 
development of surface imprinting protocols, in which MI occurs 
only at the surface of thin polymer layers or particles, instead of in 
bulk (36). This not only allows free template diffusion in solution but 
also potentially reduces the amounts needed for the imprinting pro-
cess. Nonetheless, bulk imprinting can still be a useful strategy for 
some applications (37), although the drawbacks associated with the 
applicability of MIPs for large biomolecules remain in these cases.
In addition, the strong hydrogen bonding nature of water often 
disrupts the interactions between template and monomer, a fact 
well documented in MI literature, which decreases imprinting effi-
ciency (31,  38,  39). This is especially challenging when the target 
molecule includes a high number of hydroxyl and other strongly 
hydrophilic groups (e.g., oligosaccharides in glycoproteins), which 
are strongly solvated by water. Binding these molecules thus requires 
paying a significant desolvation penalty, rendering the process thermo-
dynamically unfavorable. This is reflected in the comparatively low 
affinity of natural sugar receptors like lectins, commonly in the range 
of 103 to 104 M−1 (40, 41).
Another inherent characteristic contributing to the challenging 
imprinting of proteins is their structural complexity (31, 42). On the 
one hand, the vast number of different chemical functionalities 
spread over distinct portions of the protein potentially leads to the 
generation of heterogeneous binding sites (31). On the other hand, 
the conformational flexibility reinforces this variability, leading to 
production of inadequate cavities for later recognition (42). In prac-
tice, this results in a higher loss of entropy on rebinding, and thus 
less efficiency in the process (43). Last, a usually overlooked limita-
tion for the large-scale production of MIPs targeting biologically 
relevant proteins is their prohibitive costs, making them irrational 
options to be used as molecular templates in most imprinting 
settings (12, 16, 44).
As discussed below, several attempts have been made at creating 
MIPs for the recognition of epitopes, peptides, and proteins. Our lab-
oratories have come up with novel methods for the production of 
materials capable of binding and recognizing specific proteins (44–46). 
To minimize the diffusive limitation of a material imprinted in the 
bulk, we have focused on surface adsorption (47–49). Corre-
spondingly, our methods have been designed for the production of 
micro- or nanoparticles (NPs), to produce materials with large surface- 
to-volume ratios. In addition, a main design concern was in the 
use of solvents amenable for protein stability. To these ends, we have 
developed a surface imprinting technique whereby the template mol-
ecule is adsorbed at the interface between two distinct phases. Agita-
tion during polymerization results in the formation of droplets, with 
subsequent polymerization yielding microparticles or NPs (48).
Epitopes as alternative imprinting templates
First proposed by Rachkov and Minoura in 2000 (43), the epitope 
approach attempted to solve these issues, particularly those related 
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is analogous to the way antibodies work, by recognizing a small 
surface-exposed fragment of a larger molecule—the epitope (31, 50). 
For example, in the case of proteins, epitopes correspond to oligo-
peptides (37).
The versatility of this approach was quickly noticed by the MI 
community and different groups started to explore it, for example, 
for developing imprinting protocols in aqueous media (51) or to 
enable the oriented immobilization of templates for synthesis of 
MIPs with surface-confined binding sites (52, 53). However, this 
approach remained initially restricted to recognition of small pep-
tides (54). Building on these seminal works, by 2005 and 2006, the 
first surface epitope–imprinted sensors for the identification of full 
proteins were reported (55, 56). Around the same time, both organic- 
and inorganic-based polymers imprinted with C-terminal sequences 
or surface-exposed amino acids of whole proteins were shown to be 
effective materials for targeting model proteins such as cytochrome c 
(57) or lysozyme (58). Not long after, the bioactive potential of epitope- 
imprinted NPs was demonstrated in in vitro (59, 60) and in vivo 
(61, 62) assays.
By using a smaller compound as template, the structural and 
cost issues previously associated with larger molecules can be cir-
cumvented while retaining selective recognition and affinity for the 
larger target (Fig.  1). Their smaller size decreases intramolecular 
flexibility and the number of exposed functional groups, thus con-
tributing to greater homogeneity of imprinted cavities. Furthermore, 
peptides do not denature like proteins (since they lack tertiary and 
quaternary structures) and can be synthesized to be soluble in other 
solvents besides water. Thus, they present greater versatility in terms 
of conditions of MIP preparation (31).
On the other hand, although the smaller size of epitopes mini-
mizes problems associated with diffusion constraints for template 
removal, when used for bulk imprinting, it does not avoid the fact 
that rebinding of the corresponding target macromolecule is still 
limited by polymer mesh size. This makes epitope imprinting a 
more attractive option for strategies of surface imprinting and/or 
imprinting of nanomaterials, where binding sites are more easily 
accessible, as pioneered by Titirici (52, 53).
Smaller templates are also cheaper and easier to produce, since 
they can be chemically synthesized (36). This allows the imprinting 
of biologically relevant molecules at reasonable prices that would 
not be possible with the whole macromolecule. This is especially 
attractive in an era of increasingly numerous commercial suppliers 
of synthetic peptides, which facilitate the development and widen 
the availability of this technology.
The growing interest in MI, particularly for protein recognition, 
has been discussed by some excellent recent reviews covering this 
topic (14, 63–66). However, most of these have focused on discussing 
how this technology has been leveraged by some emerging applica-
tions. While generic MIP synthesis procedures are also addressed in 
these reviews, they focus mostly on the imprinting step per se. The 
critical earlier processes of reagent and material selection, chemical, 
and thermodynamic considerations are often overlooked, as are the 
postimprinting evaluation steps [with the exception of the review 
by Culver and Peppas (16)]. Moreover, the epitope approach is gen-
erally just briefly mentioned or included as a subsection of a larger 
topic, without particular focus on discussing its specificities. How-
ever, with the growing body of literature on epitope imprinting 
in multiple directions, it is important at this point to perform a 
thorough discussion and systematization of the most relevant de-
velopments in this field over the past decade.
Since its inception, epitope imprinting has been followed for dif-
ferent types of applications, in combination with various synthesis 
methods (67–73). However, despite its advantages, it also brings 
new concerns that must be addressed to make it an effectively useful 
approach. Questions regarding the kind of epitope to use as tem-
plate, the best functional monomers to couple with it, and which 
preparation method to follow must all be answered considering the 
specificities of the molecule (or other entity) to be targeted and the 
ultimate function it is to fulfil (Fig. 2). Here, we review the latest 
publications on the subject and discuss the ways in which research-
ers have addressed these questions.
IMPORTANT PARAMETERS FOR ANALYSIS OF MIP 
PERFORMANCE
Before exploring how the epitope imprinting approach has been ap-
plied, it is important to discuss how the recognitive potential of 
MIPs can be analyzed (66). To be able to evaluate and compare the 
performance of different MIP formulations, a common set of pa-
rameters needs to be established (Fig. 3). The binding of template 
and target to the MIP may be measured by adsorption experiments. 
The most common imprinting procedure consists in mixing the 
prepared MIP in a solution containing the target molecule, incubat-
ing for a set amount of time, followed by separation and measuring 
of the remaining concentration in the supernatant (16). The ad-
sorption capacity Q (usually expressed in milligrams of target per 
gram of MIP) is then calculated by Eq. 1
  Q =  (C0 − Ct ) V ─m  (mg  g 
−1 ) (1)
where C0 (mg ml−1) is the initial concentration, Ct is the measured 
concentration after time t, V (ml) is the solution volume, and 
m (g) is the mass of polymer incubated in it. It is also a common 
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concentrations, plotting the value of Q according to each variable. 
The resulting graphs represent, respectively, the adsorption kinetics 
and the binding isotherms. The value of Q at saturation point 
(which should be similar in both) is the maximum adsorption ca-
pacity (Qmax).
In addition, the degree to which the imprinting process affects 
the material binding affinity for the target should be determined. To 
that end, the same polymer formulation, with (MIP) and without 
undergoing the imprinting process [nonimprinted polymer (NIP)], 
should be compared. Thus, the concept of imprinting factor (IF) 
was created to quantify this effect. IF consists of a ratio between the 
ability of a given MIP and its NIP counterpart to bind the target 
molecule. Different authors use different parameters to make this 
calculation, but the most common one is Q. IF is then calculated as 
per Eq. 2
  IF =   Q MIP  ─ Q NIP 
(2)
Fig. 2. Major steps in the process of epitope imprinting. Each one presents an array of options that must be carefully considered to optimize MIP efficacy considering 
the target application.
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with QMIP being a value of Q measured (at any equilibrium concen-
tration of free solute) for the MIP and QNIP being its equivalent value 
for the corresponding NIP (16). Other works have adapted this 
concept to the corresponding application. For instance, to evaluate 
a microextraction monolith, Ji et al. (74) used the ratio of enrichment 
factors in place of Q, while works on fluorescent sensors take the 
ratio of Stern-Volmer constants instead (75, 76).
Furthermore, works using solid-phase imprinting methods to 
produce MI NPs (explored below) usually do not calculate IF val-
ues, since suitable NIPs cannot be prepared using this protocol (the 
affinity separation step cannot be performed in the absence of an 
immobilized template). As a compromise, NPs imprinted with a 
different molecule are used as alternative controls and their perform-
ances are compared based on kinetic binding constants instead of 
IF values (73, 77).
The concept of IF has been widely applied to describe the success 
of an imprinting procedure, since it is practical to measure and sim-
ple to understand. However, it has also been questioned, since it is 
relatively prone to manipulation (78). IF depends exclusively on Q, 
and this parameter varies differently for MIPs and NIPs, along with 
the concentration of target molecule. Thus, by choosing the values 
of Q that yield the highest IF, it is possible to inflate this parameter.
As complementary or alternative methods, binding studies over 
a significant concentration range have been proposed and are being 
increasingly adopted. As widely applied for the characterization of 
antibodies, binding studies are among the most reliable tests to 
characterize the affinity and specificity of an imprinted material for 
its target. There are several methods to perform this type of charac-
terization, but most of them typically imply the determination of 
the equilibrium dissociation constant, KD (24). Some of the tech-
niques and instruments commonly used for these studies are sur-
face plasmon resonance (SPR) and quartz crystal microbalance 
(QCM). Despite being based on different physical phenomena, 
both techniques can detect very fine variations of mass at the sur-
face of their sensors. A typical experimental workflow can be sum-
marized as follows. First, either the target molecule or the MIP is 
immobilized on the sensor surface. Subsequently, the binding partner 
is injected in solution/suspension at different concentrations. Then, 
the binding curves recorded by the instrument can be analyzed by 
different models to calculate either affinity or kinetic parameters. In 
the first case, the protocol needs to allow binding events to proceed 
to equilibrium, with the KD being directly calculated. In the latter, 
association (kon) and dissociation (koff) rate constants are calculated 
instead. These not only allow the determination of KD by Eq. 3 but 
also provide information on the velocity and stability of the binding 
interaction.
  K D =  
 k off  ─ k on 
(3)
There are several models to describe binding/adsorption inter-
actions that can be used to interpret the raw data and determine KD 
(79). Among the more common equations that can be applied to 
binding isotherms are the saturation equation for specific binding, 
and the Langmuir and Freundlich equations. Another method to 
simplify the calculation of KD is to trace a Scatchard plot from 
the concentration-response curves. This consists in plotting the 
response/concentration ratio against the response, to obtain a lin-
ear curve, where the slope is −1/KD. An in-depth review of these 
concepts is presented by Ansell (80).
It is also crucial to assess the selectivity of the material, which is 
done by comparing its behavior when in contact with the target 
molecule versus other substances. This can be performed separately 
(one compound at a time) or in a competitive environment (mix-
ture with multiple macromolecules) (47,  48). From these experi-
ments, it is possible to calculate another parameter, the selectivity 
coefficient (usually represented by the Greek letter ), relative to 
each competitor molecule, given by Eq. 4
   C =  
 Q T  ─ Q C 
(4)
where QT is the Q value for the target molecule and QC is the 
equivalent value calculated for a given competitor (16, 80). Competitive 
experiments can also be performed with varying target-to-competitor 
ratios, to assess the degree of interference of the latter in the binding 
process (16, 47). Selection of adequate competitors is also relevant, 
in this case. Molecules with known similarities to the target should 
be chosen, so as to test the influence of characteristics such as 
isoelectric point, size, or structure in the adsorption to the MIP (67). 
By excluding these factors, it is possible to achieve a better under-
standing of the effectiveness of MI in generating selectivity in the 
polymer (47). In the particular case of peptide epitopes, the most 
common selectivity test consists of challenging MIPs with a “scrambled” 
version of the template (69). This experimental test ensures that the 
MIP can specifically distinguish the target amino acid sequence, in-
stead of simply binding any peptide with a similar composition based 
on charge or length, for example.
Other properties commonly analyzed in MI studies refer to the 
particular envisioned application. For example, MIPs applied in sample 
purification can be evaluated for the percentage of recovery of a given 
substance from a complex mixture. Considering the scope of this 
review, these usually consist of biological fluids, such as blood (81), 
plasma (42), serum (75), cerebrospinal fluid (74), or urine (76). This 
is performed by preparing several dilutions of the mixture, spiking 
them with a known concentration of the analyte, and incubating them 
with the MIP. After MIP removal, either the MIP is analyzed to as-
sess the amount of bound analyte or the remaining target in the mix 
is quantified and subtracted from the initial spiked concentration.
In the case of MI biosensors, parameters such as the linear range 
and the limit of detection (LOD) are routinely determined to char-
acterize its functioning. The latter can be defined as three times the 
SD of the blank signal (signal-to-noise ratio of 3) (72). Last, two 
important properties for both bioseparation and biosensing appli-
cations are reusability and reproducibility. The first refers to the 
ability of the MIP to match the original performance after repeated 
use, while the latter corresponds to the precision of results between 
different measurements or batches. Reusability is assessed in terms 
of either adsorption capacity or recovery percentage retained after a 
certain number of cycles of use and regeneration (82), while repro-
ducibility is given by the SD between replicates (83).
The parameters discussed here are the ones most commonly as-
sessed in works published in the field. Regrettably, they are often not 
found together within the same study, precluding suitable compari-
sons between epitopes and preparation techniques/methods. This may 
inherently bias the results of a given work and thereby contribute to 
slowing the progress on the field, as has been previously discussed 
(78). Hence, the adoption of standard evaluation procedures, based 
primarily on binding studies and calculation of KD, would represent 
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THE FIRST STEP: CHOOSING THE EPITOPE
Since the target molecule is replaced by a smaller template, choos-
ing the best epitope candidate from the structure of its macromolec-
ular source is the first crucial step in epitope imprinting. Figure 4 
offers a concise and integrated overview of the available strategies 
for selection, as will be discussed ahead. So far, these strategies have 
mainly been applied for the recognition of proteins, since they offer 
the greatest number of specific biological interactions and effects 
(e.g., cell surface receptors, growth factors, and circulating proteins 
in blood). Therefore, the majority of selected epitopes in imprinting 
protocols consist of oligopeptides, although there is a growing in-
terest for saccharide imprinting in recent years. The imprinting of 
oligosaccharide epitopes has shown potential as an effective strate-
gy for the recognition of specific glycoproteins (40, 84), as well as 
aberrant glycosylation sites on cells (85,  86). This approach has 
opened a new path of research in the field, where significant devel-
opments can be expected in coming years.
Terminal protein sequences
Most works on peptide imprinting opt for a linear peptide that corre-
sponds to a small part of the protein sequence (primary structure). 
Following the strategies proposed by the seminal works on the sub-
ject (43, 56), the majority of papers on epitope imprinting use the 
C-terminal portion of proteins as templates. This is based on the fact 
that this site is a less frequent target for posttranslational modifica-
tions (87–89), thus increasing the chances of direct correspondence 
between the template peptide and the sequence of the protein in real 
environments. This choice also presents other important advantages 
that make it attractive in the synthesis of MIPs: (i) A linear peptide is 
cheaper to produce and avoids the complexity of secondary and ter-
tiary structures, which, as described above, can decrease imprinting 
efficiency; (ii) selected sites are frequently exposed at protein surfaces, 
which is essential for their recognition by MIPs (56, 73); (iii) they can 
be quickly selected since they can be identified just considering the 
amino acid sequence and structure of the protein (67, 90); and (iv) 
they can be easily modified with either a single amino acid [e.g., histi-
dine, terminal cysteine (73, 91)] or a custom-designed peptide se-
quence (69, 89) to facilitate particular bioconjugation reactions.
N termini have not been as commonly used as C termini (92–96). 
In works where both are used as templates, recognition results were 
shown to be superior to the use of a single template, since the corre-
sponding MIP can bind multiple sites of the protein, rendering it 
more versatile (76, 97). On the other hand, comparing the imprint-
ing performance of N- and C-terminal epitopes of the same protein 
has yielded mixed results (72, 76, 97). Overall, drawing a one-size-
fits-all conclusion and optimal criteria for the selection of protein 
epitopes is probably impossible since many physicochemical factors 
are at play in the imprinting process. In a notable example of this 
multifactorial interplay, Urraca et al. (90) attempted to imprint the 
C-terminal hexapeptide of -amyloid, but this sequence presents 
very poor water solubility, even with an acetylated N terminus, thus 
constituting a barrier to the process.
Fig. 4. Epitope selection strategies. Peptide epitopes (blue box) are by far the most commonly used type of templates in the field, although emerging strategies using 
saccharides or small molecules (yellow box) have also been shown to be potential alternatives. Complementary strategies have been increasingly applied for rational 
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MIPs prepared against this epitope in dimethyl sulfoxide (DMSO) 
demonstrated relatively high binding properties, but with an IF ≈ 1, 
i.e., no different from the corresponding NIP. To circumvent this 
limitation, the authors transformed the previous peptide into its 
tetrabutylammonium salt, which significantly improved its solubili-
ty, allowing the imprinting to take place in less competitive solvents. 
This second series of MIPs proved to be considerably more selec-
tive, with several formulations having an IF > 1.
Another important criterion to consider when choosing a linear 
peptide is how long the sequence should be. Whereas overly short pep-
tides are unable to determine a specific protein, excessively long 
peptide chains acquire flexibility and can generate intramolecular 
interactions, leading to structural conformations that may impair the 
imprinting and rebinding processes (88). According to Nishino et al. 
(56), over half of the works that used protein epitopes as templates 
chose nonapeptides, since they represent a near-unique code in 
unstructured domains for the identification of specific proteins. 
While this represents the likely minimum number of amino acids 
that can determine protein specificity, higher numbers should, in 
principle, lead to a more unique recognition. Nonapeptides have 
been found to produce MIPs with less specificity (IF) (88) and affin-
ity (KD) (98) when compared to slightly longer peptides. Moreover, 
there appears to be a closer relationship between the molecular 
weight of the peptide (instead of length) and the resulting affinity 
(98). A study verified that MIPs produced with a 9-mer peptide had 
a KD of 10 nM, whereas those imprinted against a longer but lighter 
10-mer peptide had a KD of 20 nM. Furthermore, a heavier weight 
14-mer was a slightly better selection than the lighter one with the 
same length (3 versus 5 nM). Although not definitely proven, the 
authors argue that heavier peptides may tend to maintain a more 
stable conformation during the polymerization process, thus creating 
more uniform imprinted cavities. At the other end of the spectrum, 
another study analyzed peptides of different lengths and concluded 
that chains lengthier than 16 amino acids may start to undergo in-
tramolecular interactions, negatively influencing their interaction 
with the polymers (99).
Broadening the choice
Despite the number of reports on the use of C-terminal linear pep-
tides, most of these focus on the same tried-and-tested model pro-
teins, such as cytochrome c (76, 82, 100, 101) or serum albumins 
(42, 75, 81, 88, 97, 102, 103), which provide only limited practical 
applications for this technique. However, to develop MIPs with affinity 
toward proteins with relevant interest as biomarkers or therapeutic 
targets (that invariably have prohibitive costs), more rational ap-
proaches have to be devised. Recent efforts to widen the spectrum 
of target proteins have begun to use different strategies for selecting 
the template. Table 1 systematizes these strategies, providing the 
rationale behind the choice of each epitope, as well as the target 
protein, corresponding application, and reported performance.
For example, to detect regenerating protein 1B (REG1B), a bio-
marker for pancreatic ductal adenocarcinoma, the protein sequence 
was scanned alongside other proteins of the same family, such as 
REG3, REG4, and aggrecan (99, 104). Multiple peptides were selected 
from various portions of the protein (named peptide nos. 1 to 7), 
considering properties of interest for the specific work, namely, 
physicochemical characteristics (such as solubility in an adequate 
solvent) and a sufficient number of different amino acids between 
the proteins to avoid cross-reactivity. In their first work, despite the 
best theoretical peptide (no. 2) being coincident with the C-terminal 
16 amino acids of REG1B, the authors show that sensors imprinted 
with peptide no. 4 show a higher accuracy, likely due to its greater 
exposure at the surface of the protein (104). In the follow-up work, 
peptide no. 7–imprinted sensors showed the best performance, in 
this case, thanks to the good solubility provided by the six charged 
and three polar amino acids in the 13-mer sequence (99).
While the previous works sought to avoid cross-reactivity with pro-
teins of the same family, others have looked for the opposite response. 
Another epitope selection method that has been successfully applied 
consists in identifying small sequences common to a target family of 
peptidic molecules, such as neurotransmitters, hormones, or toxins [e.g., 
Asp-Arg-Val for angiotensins I and II (93), Trp-Asp-Met-Phe for chole-
cystokinins (74), Tyr-Gly-Gly-Phe for enkephalins (68), and Trp-Cys 
for amanitins (105)]. This allows the resulting MIP to bind multi-
ple molecules that share the same amino acid sequence, proving to 
be versatile tools with unmatched IF values (24.5 to 33.2). The same 
principle was applied to prepare membranes for monoclonal antibody 
purification from cell culture supernatants (106). Immunoglobulin G 
(IgG) molecules are composed of a variable antigen binding (Fab) re-
gion and a constant fragment crystallizable (Fc) region. By imprint-
ing the C-terminal decapeptide of the IgG heavy chain (part of the 
Fc region), the prepared membranes could rebind full IgG mole-
cules regardless of their target antigen, thereby constituting prom-
ising versatile tools for commercial production of antibodies.
In another study, seeking to build a platform for detection of 
natriuretic peptide hormones in blood samples, nonapeptide epi-
topes were selected on the basis of the similarity of isoelectric point 
compared to the original hormone and to have a balanced hydro-
phobic to hydrophilic amino acid ratio (107). This template choice 
led to impressive KD values between 2 and 20 pM, an LOD in the 
same range, and little to no reported cross-reactivity. It is thus pos-
sible to observe that a more varied and careful epitope selection, 
considering physicochemical properties, has been shown to elevate 
the performance of resulting MIPs. This is of particular importance 
when adding to the imprinting equation the functional monomers 
that will compose the polymer, as will be discussed ahead.
Approaching biology: Looking for naturally 
occurring epitopes
Another interesting strategy for rational epitope selection goes back 
to the root of the epitope approach: immune recognition by anti-
bodies. If the concept of epitope is itself inspired by this interaction, 
why not follow it to its logical conclusion and use already established 
immunogenic regions? That is what several studies have tested. In 
one of these, the authors first looked for known binding sites on the 
anthrax protective antigen 83, an essential protein for this bacterium 
to infect mammalian cells (98). Two regions were picked, one iden-
tified as responsible for interacting with cell receptors and another 
that was recognized by antibodies. QCM sensors were then covered 
with a layer of MIP produced against each one of the templates. 
Both MIP sensors were found to bind the respective domain, as well 
as the whole protein, at particularly high affinities (KD in the dozens 
of picomolar range).
Similarly, a QCM sensor for HIV was imprinted with a sequence 
corresponding to a major immunodominant region of HIV-1 gly-
coprotein 41 (gp41; residues 579 to 613), resulting in a KD similar to 
that of monoclonal antibodies (3.17 nM) and a detection limit for 
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Table 1. Epitopes chosen for molecular imprinting according to the applied selection criteria, their respective target molecule, application, and 
reported performance. NR, not reported. 
Epitope selection 
criteria
Target molecule Epitope sequence/molecule Application Performance* Ref.
C terminus Human serum albumin 
(HSA)
AASQAALGL
Bioseparation Q = 46.6 mg g−1 (42)
IF = 4.9
Bioseparation Q = 103.67 mg g−1 (81)
IF = 2.57
Sensing LOD = 26 ng ml−1 (102)
IF = 6.9
KLVAASQAALGL




Sensing KD = 0.0254 mg ml−1 (75)
IF = 4.8
Sensing LOD = 0,02 ng ml−1 (103)
-Amyloid
GGVVIA (isoform 42)
Bioseparation IF = 2.6 (90)
KA = 89 mM−1
Q = 4.7 mol g−1
MVGGVV (isoform 40)
IF = 5.3
KA = 154 mM−1
Q = 4.8 mol g−1
Immunoglobulin G 
(IgG) heavy chain QKSLSLSPGK
Bioseparation Q = 30 g cm−2 (106)
Bioseparation KD = 27.4 nM (168)
Insulin NR Sensing LOD = 7.24 fM (197)
Epidermal growth factor 
receptor (EGFR) SLNITSLGLRSLKEISDG
Sensing LOD = 3 nM (167)
Targeted drug delivery KD = 3.6 nM (77)
Human VEGF IKPHQGQHI Targeted drug delivery KD = 1.78 nM (73)
2 microglobulin (B2M) RVNHVTLSQPKIVKW Targeted drug delivery and bioimaging
KD = 52 nM (169)
KIVKWDRDM
Bioseparation KD = 208 nM (172)
IF = 6.5
Myoglobin NYKELGFQG Bioseparation IF = 5.6 (172)
Cytochrome c (Cyt c)
YLKKATNE
Sensing LOD = 3.6 ng ml−1 (222)
IF = 3
AYLKKATNE
Bioseparation Q = 86.47 mg g−1 (100)
IF = 3.48
Q = 780 mg g−1 (82)
IF = 11.7
Q = 67.6 mg g−1 (101)
IF = 4.54
Q = 1.32 mg g−1 (223)
IF = 3.94
Sensing LOD = 89 nM (76)
IF = 4.24
Porcine serum albumin 
(PSA) VIEIRGILA
Bioseparation Q = 45.06 mg g−1 (97)
IF = 4.5
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Target molecule Epitope sequence/molecule Application Performance* Ref.
N terminus Folate receptor  QTRIAWARTELLNVAMNAKH Targeted drug delivery KD = 5.72 nM (94)
IF = 6
Cyt c GDVEKGKKI Sensing LOD = 89 nM (76)
IF = 1.88















IF = 3.5 (96)
IF = 5.46 (199)




LHTDGDKAF Targeted bioimaging 
and drug delivery
IF = 5.1 (198)








SCSGFKKWKDESCEKK (p2) Sensing KD = 25.17 pg ml−1 (104)
KSWDTGSPSSANAGYCAS (p4) IF = 2.9 (p2)
KESSTDDSNVWIG (p6)
IF = 2.6 (p4)
IF = 3.0 (p6)
NEDRETWVDADLY (p1) Sensing and 
bioseparation










Class 3 outer 
membrane protein 
allele of N. 
meningitidis
KGLVDDADI Sensing LOD = 15.71 ng ml−1 (111)
IF = 3.34
fbpA periplasm protein 
of N. meningitidis
KPYAKNSVALQAV Sensing LOD = 1.39 ng ml−1 (112)
IF = 12.27
Proline-tRNA ligase 
protein of M. leprae
LDIYTTLARDMAAIP Sensing LOD = 0.161 nM (109)
IF = 8.28
HIV-1 glycoprotein 41 
(gp41)
RILAVERYLKDQQLLGIWGCSGKLICTTAVPWNAS Sensing KD = 3.17 nM (for 
epitope, not protein)
(108)
CGSWSNKSC Targeted drug delivery KD = 85.4 nM (117)
Troponin T (TnT) 
isoform 6






VKKSDEYTF (71–79) Sensing KD = 20 pM (98)
RYDMLNISSLRQDG (659–672) KD = 10 pM
YNDKLPLYISNPNY (681–694) KD = 20 pM
DKLPLYISNPNY (683–694) KD = 30 pM
NGDTSTNGIK (713–722) KD = 200 pM
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Target molecule Epitope sequence/molecule Application Performance* Ref.
Neuron-specific enolase 
(NSE)
AMRLGAEVYHTL Sensing KD = 0.23 nM (Cys) (91)
IF = 8.8 (Cys)
KD = 0.03 nM (His)




C*PLHNQEKCSKPC*ARV Targeted drug delivery NR (118)





C1NC2KAPETALC1TNYC2FRN Tissue engineering NR (48)
NSE LKAVDHINST Sensing KD = 53 pM (113)
CKGVLKAVDHINSTIAPC Sensing KD = 26 pM (89)
9 < IF < 10
Transferrin CGLVPVLAENYNK Bioseparation KD = 2.0 nM (190)
IF = 1.6
Cardiac troponin I NIDALSGMEGR Bioseparation KD = 23 nM (190)
IF = 1.9




Cholecystokinins WMDF Bioseparation Q = 0.73 mg g−1 and 
IF = 24.5 (CCK5)
(74)
Q = 1.1 mg g−1 and 
IF = 28.3 (CCK8)
Enkephalins YGGF Bioseparation Q = 1.2 mg g−1 and 
IF = 32.2 (Met-
enkephalin)
(68)
Q = 0.94 mg g−1 and 
IF = 33.2 (Leu-
enkephalin)
Angiotensins I and II DRV Bioseparation LOD = 0.07 ng ml−1 and 
IF = 4.9 (ang I)
(93)
LOD = 0.06 ng ml−1 and 
IF = 5.2 (ang II)
Amanitins WC Bioseparation IF = 6.5 (105)
KD = 112.7 g liter−1







RMDRIGAQSG Sensing KD = 20 pM (107)
Brain natriuretic 
peptide
FGRKMDRISS Sensing KD = 2 pM (107)
Single amino acid IgG l-lysine Bioseparation Q = 75.1 mg g−1 (142)
IF = 1.93
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was also followed to prepare MIP-coated QCM sensors for de-
tection of Mycobacterium leprae, attaining an order of magnitude 
lower LOD (0.161 nM) (109). The epitope selected by the authors 
had previously been shown to stimulate interferon- secretion by 
T cells from infected patients, thus being identified as a natural 
antigen (110).
In another study, SPR sensors were simultaneously imprinted 
with four peptide residues of cardiac troponin T (TnT), along with 
Epitope selection 
criteria






PPA Bioseparation Q = 7.35 mg g−1 (154)
IF = 2.5
Q = 23 mg g−1 (153)
IF = 1.8
Q = 66 mg g−1 (156)
IF = 3.6
Q = 32 mg g−1 (70)
IF = 4.59
Sensing LOD = 0.37 M (155)
IF = 2.68
Monosaccharides Glycosylation sites N-acetylneuraminic acid,  glucuronic acid Targeted bioimaging IF = 3.1 (glucuronic 
acid)
(157)
IF = 2.4 (N-
acetylneuraminic 
acid)
Targeted bioimaging KD = 141 M (glucuronic 
acid)
(158)
KD = 24 M (N-
acetylneuraminic 
acid)
N-acetylneuraminic acid Targeted bioimaging KD = 1.7 × 10−4 M (85)
Hyaluronic acid (HA) d-glucuronic acid Targeted bioimaging KD = 800 nM (159)
IF = 3.2 (86)
Monosaccharide 
and single amino 
acid
Telavancin Mannose-tryptophan Bioseparation IF = 3.0 (160)
Q = 6.26 mg g−1






RNase B Man5GlcNAc2, Man6GlcNAc2 Bioseparation KD = 24.89 M (139)
IF = 8.4Man7GlcNAc2, Man8GlcNAc2
Transferrin NR Bioseparation IF = 21.8 (139)
HER2 NR Targeted drug delivery 
bioimaging
IF = 8.02 (84)






Hemoglobin VLSPADK, VHLTPEEK (among others not 
specified)
Bioseparation IF < 2 (67)
Pro-gastrin releasing 
peptide (ProGRP)
NLLGLIEAK Bioseparation KD = 3.4 × 10−6 M (140)
Q = 59 × 10−3 mol g−1
KD = 7.1 × 10−6 M (141)
Q = 39 × 10−6 mol g−1
*Imprinting factor (IF) is given for all works where it is reported. Dissociation constant (KD) is the preferred performance parameter and is provided for all works 
that report it. When KD is not available, the most adequate parameter reported in each study is provided, namely, limit of detection (LOD) for sensing and 
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sensors imprinted with each single epitope (72). These corresponded 
to the N and C termini of TnT and to two epitopes recognized by 
commercial antibodies. In this case, only the C terminus– imprinted 
sensor significantly detected TnT, and its performance was close to 
the sensor imprinted with the four peptides. Thus, the authors con-
cluded that only that fragment was responsible for the specificity of 
the MIP. Considering the two epitopes recognized by antibodies, 
the authors suggest that molecular constraints of the inner portions 
of the protein could represent an obstacle to properly match the 
shape produced by linear peptides in the MIP. Instead, for the 
N-terminal epitope, unfavorable electrostatic interactions between 
the highly acid peptide and negative dopamine monomers were 
suggested as responsible for the failure of its MIP. From these stud-
ies, it is then possible to conclude that multiple factors, besides the 
type of epitope per se, affect the imprinting efficiency. These will be 
discussed in more detail further ahead.
Using previously verified antigenic determinants may also be 
unfeasible when the target protein has not yet been extensively 
studied. In these cases, bioinformatics tools can help visualize critical 
domains and predict candidate epitopes. This approach has been 
used to develop sensors to target the bacteria Neisseria meningitidis, 
by targeting exposed sequences of certain surface proteins (111, 112). 
Nonapeptides from exposed immunogenic loop VII of class 3 outer 
membrane protein (111) and a 13-mer epitope of iron requisition 
protein (112) were separately tested as MI templates. Both MIP- 
coated sensors were successful in detecting the target bacteria in 
blood samples of patients with brain fever.
In a similar strategy, the x-ray crystallographic structure of neuron- 
specific enolase (NSE) was analyzed to select a surface-exposed 
12-mer sequence as template for this cancer biomarker (91). Recent-
ly, molecular dynamic simulations have been performed to predict the 
most structurally stable epitopes after screening the structure of NSE 
(89, 113). Sensors imprinted with the best candidate epitope achieved 
an affinity of 53 pM, significantly higher than similar sensors im-
printed with the C-terminal nonapeptide of cytochrome c, for exam-
ple. Furthermore, when sensors were imprinted with the peptide 
predicted to be the least stable, their binding to NSE produced 
signals three to five times lower than sensors imprinted with the most 
stable peptide (113), demonstrating that this computational analysis 
can be a very useful tool for refining the epitope search.
Beyond a linear amino acid chain
Another rather recent innovation on epitope design is that of con-
formational epitopes. As described above, the vast majority of avail-
able literature reports the use of linear peptides. Notwithstanding, 
the prevailing mode of recognition mechanisms in nature is instead 
based on interactions with secondary and tertiary structures of pro-
teins (particularly for antibody-antigen interactions, the inspiration 
for epitope MIPs) (71, 114, 115).
To recapitulate these mechanisms, Cenci et al. (116) used a cyclic 
peptide (CC9ox) mimicking the apical portion of the -hairpin hor-
mone hepcidin-25 as imprinting template. The selected epitope 
maintained a stable circular structure thanks to a cysteine bridge be-
tween its C- and N-terminal cysteine residues. In this breakthrough 
work, the authors show that MIP NPs (MINPs) could selectively rec-
ognize the full hormone molecule at high affinity (KD = 9 ± 1 nM), 
while having no measurable interaction with the linear scrambled 
version of the template peptide. These MINPs could act as “artificial 
chaperones” by favoring the folding of the linear version of the 
template peptide into its structured form, opening exciting prospects 
for future treatment of diseases involving protein misfolding. In a 
similar approach, MINPs were developed to serve as plastic anti-
bodies against HIV infection (117). The authors used molecular 
modeling to design a cyclic peptide that contained part of a natu-
ral epitope of the target gp41 (SWSNKS), which is usually used to 
produce antibodies. Although this sequence is smaller than the 
recommended eight amino acids, KD for the MINP/gp41 interac-
tion was 85.4 nM, while cross-reactivity varied between 0.1% 
(transferrin) and 1.6% (human serum albumin). The cyclic de-
sign of the peptide, mimicking the natural conformation of this 
epitope, might have played an important part in these results, ac-
cording to the authors.
A different group devised a refined conformational epitope design 
workflow to target human epidermal growth factor receptor 2 (HER2), 
an overexpressed receptor in a significant number of cancer cells 
(118). Starting with the use of the Immune Epitope Database server 
(119, 120) to perform epitope mapping, PyMOL (121) and ElliPro 
software (122, 123) were then applied to design four candidate confor-
mational epitopes. Protein-protein BLAST (BLASTP) (124) was then 
used to score the best candidate, ensuring the highest correspondence 
to the target protein HER2 while having the lowest possible cross- 
reactivity with other unrelated proteins. The produced MINPs (loaded 
with doxorubicin) were able to significantly increase the drug’s con-
centration in the tumor, while reducing its off-target distribution in 
healthy tissues. They also more than doubled cumulative survival of 
mice in the experimental group, compared to controls.
Another innovative approach was taken by Zhang et al. (71), 
where the apamin peptide toxin was used as a scaffold to recreate 
the exposed N-terminal  helix of hyaluronan-binding protein 1 
(HABP1/p32, another overexpressed surface receptor in cancer cells), 
which serves as a specific recognition motif. Following the previous-
ly proposed strategy for conformational epitope design (125), the 
original apamin residues were replaced with topologically equiva-
lent residues from p32 (Fig. 5A). However, the ninth alanine (that 
exhibits the highest  helix propensity) and two cysteines (for 
disulfide bond stabilization) were maintained to preserve the 
peptidic structure. MINPs were able to efficiently target different 
tumor tissues at different anatomical sites, leading to substantial re-
duction in their growth.
The previous strategies have recently been combined by our 
groups to design a conformational epitope for transforming growth 
factor–3 (TGF-3) (48). The protein structure was scanned for 
surface-exposed domains that did not interfere in receptor binding 
using The US Research Collaboratory for Structural Bioinformatics 
(RCSB) Protein Data Bank (PDB) (126, 127) and PyMOL software, 
followed by BLASTP to score their uniqueness. Since the N-terminal 
 helix portion showed the best results, apamin was used as a 
molecular scaffold to prepare the epitope, as previously demonstrated 
(71, 125). The structure of the novel hybrid peptide was predicted 
and compared to the native epitope using PEP-FOLD 3 De novo 
peptide structure prediction server (128, 129). It showed a spatial 
distribution of side chains similar to native protein epitope structures 
(Fig. 5B). Acrylamide-based MINPs were then produced by inverse 
microemulsion polymerization (130) and were shown to selectively 
bind the full TGF-3 from a complex biological fluid (platelet lysate) 
despite being present at a significantly reduced concentration 
compared to proteins with similar structure (TGF-1) and isoelectric 
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A key concept for the success of the previous works was the use 
of bioinformatic tools for a process named fingerprint analysis. 
Originally proposed by Bossi et al. (131), this streamlined process 
for the rational selection of an idiotypic (i.e., unique) peptide epi-
tope consists of the following basic steps: (i) select a target protein 
sequence and obtain it from the database [National Center for Bio-
technology Information (132), UniProt (133), RCSB PDB, etc.]; (ii) cut 
it in silico into peptides by choosing a suitable cutting agent (e.g., 
trypsin) using ExPASy PeptideCutter (134, 135); following previously 
mentioned studies (56, 88, 98, 99), peptides that are too small or too 
long should be discarded; (iii) peptides of adequate length (8 to 
15 amino acids) are aligned to the whole database using BLASTP; the 
best epitope is the one that best matches the parental protein (highest 
S score) while simultaneously having the lowest E value (represent-
ing the number of distinct alignments that occur in the database by 
chance). While this workflow has been proposed for linear peptides, 
our work (48) shows that it can also be adapted to conformational 
peptides, by including 3D visualization, surface functionality as-
sessment, and secondary structure prediction steps, using platforms 
such as Mol* (/'molstar/) (136), PyMOL, or PEP-FOLD 3.
Direct epitope extraction from target 
macromolecule digestion
A recently introduced alternative strategy circumvents the step of 
choosing the epitope a priori (67). In this work, the target protein 
hemoglobin was immobilized on the surface of aldehyde-modified 
silica NPs (SNPs), which served as a solid-phase support. Then, 
these were subjected to denaturating conditions and digested with 
trypsin, with only the covalently bound fragments remaining at the 
surface of the particles. In this manner, a variety of surface-exposed 
peptides from hemoglobin could be imprinted, which, theoretically, 
should increase the effectiveness of the process, compared to the 
imprinting of a whole protein or a single epitope. Nonetheless, this 
approach requires the use of the full protein with its associated dis-
advantages, particularly regarding cost of implementation when 
working with expensive recombinant proteins as molecular targets. 
Moreover, despite a certain degree of selectivity being observed, the 
IF and selectivity coefficients were lower than 2, some of the lowest 
among the present selection of works. This indicates that this strat-
egy still needs further refinement before becoming a viable option.
A similar approach that has achieved comparatively improved 
results is termed boronate affinity–controllable oriented surface 
imprinting (137). This method likewise relies on the digestion of 
the protein to isolate epitopes for imprinting. However, instead of 
peptides, glycans are used. Although it limits the applicability to gly-
cated proteins, this is often the case for extracellular or membrane- 
associated proteins with extracellular portions (138), which should 
be the ones most accessible for MIP applications. Moreover, these 
glycan sequences are exposed at the surface of proteins, as necessary 
for interaction with the polymer. By using various oligosaccharide 
sequences from the same protein [e.g., ribonuclease B (RNase B), 
transferrin (139), HER2, and erythropoietin (84)], a near-unique 
MIP can be prepared, achieving impressive selectivity (coefficients 
> 3.5). The use of saccharides as templates also offers an easy route 
for their immobilization onto a solid-phase support for polymer-
ization, by exploring their affinity for boronic acids. These covalent 
bonds are established at relatively high pH values and reversibly 
dissociate at acidic pH, therefore proving to be an efficient method 
for removal of the template after imprinting. The major draw-
back in these systems appears to be the relatively low affinity for 
the target molecule (KD in the micromolar range), although this 
is to be expected for saccharide binding in aqueous media, as 
discussed before. Furthermore, the NP composition might also 
have played a role. Because tetraethyl orthosilicate (TEOS) was 
used as the only functional monomer, perhaps it did not provide 
the most adequate interactions with the template molecules for 
high MIP affinity.
Protein digestion can also be used as a preliminary procedure to 
identify proteotypic peptides for later epitope imprinting (140, 141). 
This approach has been used to improve the speed and effectiveness 
of proteomic analysis, allowing precise identification of the signa-
ture nonapeptide of pro-gastrin–releasing peptide (ProGRP) in 
tryptic digests of serum samples.
It has been shown that smaller molecules can also be used as tem-
plates to target some specific proteins. For example, on the basis of the 
frequency of l-lysine residues in Fc fragments of IgG molecules, 
l-lysine–imprinted cryogels were prepared for IgG adsorption (142). 
Since a single amino acid cannot be nearly as idiotypic as a peptide, the 
values of IF and selectivity coefficients were, understandably, relative-
ly low (<2). Nonetheless, it performed relatively well in real sample 
analysis, with up to 90% of IgG being removed from diluted serum. 
Similarly, the Sellergren group (143–149) has explored the use of 
fluorenylmethyloxycarbonyl-protected phosphorylated single amino 
acids as template epitopes for the selective separation of phosphory-
lated peptides, with a focus on phosphotyrosine (pY). This strategy 
has been successfully validated against the commonly used approaches 
based on TiO2 and anti-pY antibodies (145) and has been used in 
combination with TiO2 to selectively enrich a protein extracts from 
cancer cells in phosphopeptides before mass spectrometry analysis 
(146), suggesting that this method can be a valuable alternative for 
applications in phosphoproteomics research. This strategy has also 
been recently expanded to selectively bind phosphoserine (150, 151) 
and phosphohistidine (152) residues, demonstrating its versatility.
Selection of non–peptide-based epitopes
Last, some authors have also explored epitope imprinting using 
other types of template molecules beyond peptides and amino acids. 
In several works, phenylphosphonic acid (PPA) was used as an al-
ternative dummy template for detection and isolation of peptides 
containing pY residues, since PPA and pY have remarkable similar-
ity. This method has been optimized over recent years, achieving 
steadily improving results in terms of affinity, adsorption capacity, 
and selectivity (70, 153–156).
Fig. 5. Construction of conformational epitopes using apamin as molecular 
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Monosaccharides such as glucuronic acid and N-acetylneuraminic 
acid have also demonstrated their effectiveness as epitope templates. 
NPs imprinted with these epitopes were successfully used to target 
and fluorescently label specific glycosylation sites in proteoglycans 
or glycans such as hyaluronic acid (HA), based on the relative abun-
dance of these sugar monomers in these macromolecules (157–159). 
Furthermore, they showed no cross-reactivity with other monosac-
charides commonly found at the terminal end of sugar chains from 
proteoglycans or glycoconjugates existing on cell surfaces. Last, a 
combination of a single monosaccharide (mannose) and a single 
amino acid (tryptophan) was shown to be enough to imprint micro-
spheres capable of identifying the glycopeptide antibiotic telavancin, 
with an IF of 3.0 (160). However, a more recent study used the exact 
same template to produce similar microspheres for the antibiotic 
teicoplanin (161). The authors analyze the selectivity of this MIP 
when challenged with telavancin, demonstrating insignificant re-
covery from solution (≈10%), contrasting with the previous results. 
Although the chemical composition of the MIP was slightly differ-
ent, it is hard to explain this apparent contradiction, a fact that is 
also not commented by the authors.
As described over the course of this section (and summarized in 
Fig. 4), the selection of the right epitope for MI is not a linear pro-
cess. One must take into account a range of factors, from the specific-
ities of the target molecule (proteins having been the most exploited), 
to the accessibility of the corresponding fragment (surface-exposed 
regions), the size of the dummy template (if too long, it might hinder 
the MIP synthesis; if too short, it might not confer specificity), or its 
physicochemical (solubility; pI) and structural properties (linear 
versus conformational). However, as mentioned above, the choice 
of epitope itself is only one of the parameters of this technique, and 
its choice must simultaneously consider other MIP design factors, 
as will be discussed in the next section.
FUNCTIONAL MONOMERS FOR EPITOPE IMPRINTING
MI involves the polymerization of a functional monomer solution 
in interaction with the template. The final affinity of the produced 
MIP is influenced by the strength of these interactions, which are 
crucial for the formation of recognition sites and, consequently, 
their selectivity (162). As such, the monomers chosen, alongside 
their solvent, are also important parameters in the imprinting equa-
tion (43). The epitope approach presents a significant advantage in 
this matter. Since macromolecules of interest are replaced by their 
smaller epitope templates, which do not have complex structures, 
the limitations of water solubility and stability are generally mini-
mized, and a greater variety of synthesis protocols can be applied 
and compared for imprinting efficiency.
Acrylic acid, acrylamide, and derivatives
By far, the most common option is the use of acrylic acid, acryl-
amide, or their derivatives (30, 43, 44, 75, 84, 91, 159, 163). All of 
these monomers offer the ability to interact via hydrogen bonds, 
versatile noncovalent interactions with a binding energy between 1 
and 40 kJ mol−1 (164). H-bonding is especially prevalent between 
organic compounds, which correspond to the chemical nature of 
the epitope templates discussed in the previous section, making it a 
desirable feature for the backbone monomer of imprinted polymers. 
Moreover, acrylic acid and acrylamide derivatives are used in a 
variety of fields, and their free-radical polymerization process is 
well studied and established, which helped to repurpose these com-
pounds for MI (165).
Following the strategy proposed by Hoshino et al. (166), in re-
cent years, N-isopropylacrylamide (NIPAAm), alone or mixed with 
other acrylates, has also become a popular base monomer for MIP 
synthesis (73, 77, 96, 159, 167–169). In general, these works follow 
protocols of polymerization in mild conditions, ideal for biological 
macromolecules. Phosphate-buffered saline (PBS) is adopted as the 
solvent, thus avoiding harmful organic solvents, with reactions usu-
ally being carried out at room temperature, without any need for 
sophisticated and expensive equipment. Furthermore, poly-NIPAAm 
also has another well-known useful attribute: thermoresponsiveness. 
It undergoes a phase transition at 32°C (its lower critical solution 
temperature) from a swollen hydrated state to a shrunken dehydrated 
state (76). This intrinsic property enables its exploitation for the 
binding and release of target molecules at select temperature intervals, 
which is useful, for example, in drug delivery (117, 169) or sample 
purification (81, 156, 168).
Another widely selected monomer derived from acrylic acid is 
zinc acrylate, due to its ability to establish metal chelation interactions 
and form heterocycles with the template (81, 82, 97, 102, 154, 170, 171). 
Several works have shown that this introduction of an extra type of 
possible interactions beside the common H-bonds can increase the 
strength of the template-functional monomer complex. This results 
in a higher number of binding sites and, consequently, improved 
affinity and binding capacity of the MIP (81, 97).
Other organic monomers
Among other commonly used monomers is dopamine (72, 108, 118). 
Mainly known as a neurotransmitter, in alkaline conditions, the 
catechol group is oxidized to quinone form, which self-polymerizes 
into an adhesive polymer with high stability, hydrophilicity, and 
biocompatibility (108). Dopamine is especially advantageous when 
interacting with tendentially basic peptides, since the quinone 
moiety preferentially interacts with basic amino acid residues (72). 
O-phenylenediamine (103) and scopoletin (89, 91) are two inter-
esting monomers that have also been tested in MI protocols because 
they can be processed by electropolymerization. This process offers 
precise control over the thickness of the MIP layer, depending 
on the applied voltage and number of cycles. This feature makes 
them particularly attractive for the development of MIP-coated 
gold sensors for QCM or SPR, for example, although other types 
of sensors such as gold wires have also been successfully im-
printed (89, 91).
In a combination of techniques, 3-sulfopropyl methacrylate/benzyl 
methacrylate MINPs were first produced, followed by electropoly-
merization of 4-aminothiophenol to bind the particles together, coat-
ing a QCM sensor (109). The new MIP achieved remarkable results, 
with an IF of 8.28, a selectivity coefficient of 4.34 against the same 
peptide with just two amino acids switching positions in the sequence, 
and a subnanomolar LOD. Other less commonly used polymers such 
as poly(ethylene-co-vinyl)alcohols (EVALs) have recently been applied 
for epitope imprinting, owing to their tunable ethylene to vinyl ratios 
that can be optimized for each given template (99, 104). Furthermore, 
EVAL films can be prepared by simple evaporation of the solvent 
(namely, DMSO), which also makes them attractive for sensor coating, 
for example. In addition, it remains to be studied how MIP produc-
tion in different solvents affects their interaction with target macro-
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because, for example, peptide templates could acquire aberrant 
conformations that mask key amino acids from the native protein.
Given the limited set of possible molecular interactions offered 
by the most commonly used monomers, Zhang et al. synthesized a 
brand-new functional monomer simultaneously combining the 
properties of ionic liquids and -cyclodextrins, which might be con-
sidered promising MIP monomer candidates due to their design-
ability and facile functionalization (101). This new monomer could 
establish various types of interactions with the template in aqueous 
medium, including H-bonding, - stacking, electrostatic, hydro-
phobic, dipole-dipole, and steric effect. This was reflected on the 
higher binding energy predicted between the template and the new 
monomer than between template and other commonly used mono-
mers that preferentially establish H-bonding interactions. Empirical 
results then confirmed the prediction, with the new MIPs achieving 
an IF of 4.54 and selectivity coefficients of up to 9.66.
Inorganic MIPs
An alternative to the previously discussed organic polymers is the 
preparation of silica structures from silane precursors. SNPs have 
attracted attention for a number of interesting properties, such as 
suggested biological inertness, the possibility of varied surface mod-
ifications, precisely controllable size depending on the cross-linking 
time, the creation of mesoporous structures, or their transparency 
to visible light (70, 75, 84, 100, 139). This has allowed their utiliza-
tion for different applications.
For example, mesoporous silica NPs (MSNs) are structures with 
a greatly increased surface area, leading to higher adsorption capac-
ities, placing them at the forefront of bioseparation and purification 
strategies (70, 100). In MSN production protocols, it is important to 
choose a surfactant that allows the mesopores to be big enough for 
suitable molecular diffusion. This choice needs to be done in a case-
by-case basis, according to the size of the target macromolecule (100). 
Alternatively, imprinted SNPs can also work as coating for a magnetic 
core, to facilitate bioseparation processes by applying a magnetic 
field (139, 172). The transparency of SNPs also allows their cou-
pling with smaller fluorescent NPs [such as carbon or other quantum 
dots (QDs) (75, 155)]. This combination can allow, for example, 
tracking of NP localization in living tissues, bioimaging, or efficient 
detection of target molecule binding through fluorescence quench-
ing. Moreover, silica’s purported inertness is essential for the safe 
use of some of these fluorescent NPs in vivo by forming a biocom-
patible shell that impedes leakage of toxic heavy metals (155).
Another advantage of SNPs is the ease of surface modification. 
While polymeric MINPs, in principle, need to incorporate specific 
monomers during polymerization to acquire particular surface 
groups, silica-based MINPs can be grafted specific functionalities 
post factum by silanization (173). One downside of this strategy is 
that binding sites may become sterically hindered or even compro-
mised by the subsequent modification. Moreover, if the various 
functional silanes are not included in the initial imprinting mixture, 
the interaction between template and silica MINPs could be rela-
tively weak [as previously mentioned (84, 139)].
Choice of cross-linker
Depending on the aimed MIP application, the choice of cross-linker 
might be as important as the choice of monomers, but the reality is 
that this design parameter has generally not been a major concern 
of most studies. The vast majority has used the same classical reagents, 
such as the homobifunctional N,N′-methylenebisacrylamide 
(48, 71, 73, 77, 167, 174) and ethylene glycol dimethacrylate 
(36, 42, 43, 47, 84, 98, 156, 168, 169), each having two vinyl groups 
that can cross-link acrylate-based monomers, or TEOS, a homo-
tetrafunctional silica-based monomer (70, 75, 84, 139, 172). Despite 
their well-known properties and effectiveness, these molecules do not 
provide any particular functionality or advantage to synthesized MIPs.
However, this untapped potential hidden in cross-linkers has 
been increasingly noticed and realized. For example, polyethylene 
glycol diacrylate has been used for its hydrophilic properties, to reduce 
nonspecific protein adsorption (153, 154), while divinyl benzene 
was used in a different work to introduce - stacking interactions 
with another functional monomer (161). A recent study has taken 
cross-linker selection a step ahead, developing MINPs for targeted 
drug delivery using a monomer and cross-linker that selectively 
degrade in tumoral tissues (96). In this elaborated strategy, the ac-
tive targeting potential provided by epitope imprinting of a cancer 
cell overexpressed surface biomarker (CD59) ensured their selec-
tive tumor accumulation and cellular uptake. The following MINP 
biodegradation in tumor tissues through the combined actions of 
glutathione over the cross-linker N,N′-diacrylylcystamine and the 
lower pH over the monomer dimethylaminoethyl methacrylate 
enabled the localized release of a chemotherapeutic drug, doxorubicin, 
at the tumor site, protecting healthy cells from its cytotoxic effects. 
This led to an effective reduction in the growth of tumor volume 
and weight, which were less than 40% than those observed with 
pure doxorubicin treatment.
Although, thus far, only a few studies leveraged on cross-linker 
properties to define MIP functionality, cross-linking designs are ex-
pected to become a major synthesis parameter for their specific per-
formance. This could be especially attractive, for example, in tissue 
engineering and regenerative medicine, where biodegradability is a 
crucial parameter for biomaterial-based scaffold construction (175). 
Other applications where responses must be limited to a specific 
time window or confined to a specific site could also benefit from 
similar degradable polymers. Therefore, the incorporation of novel 
cross-linking chemistries and molecules in MIP design will further 
expand the usefulness of MI technology to a greater variety of fields 
in the near future.
Combining previous scattered design knowledge to evolve 
MIP performance
Overall, MIP design benefits from the inclusion of different types of 
noncovalent interactions to decrease the overall binding energy 
between template and monomers, thereby increasing the affinity 
and specificity of the final polymer. The greater the number of 
building blocks used, the more unique the final construct will be. 
Table  2 summarizes the different monomers used in reviewed 
works and the molecular interactions they offer. The choice of func-
tional monomers must be made considering the template, so as to 
adapt and maximize the intermolecular interactions happening 
between the two. For example, in the case of peptide epitopes, 
analyzing their amino acid composition in terms of hydropathy and 
charge (as well as their positioning and spatial distribution for peptides 
with a secondary structure) can help to select rational monomer candi-
dates for imprinting. Moreover, the optimization of monomer to mono-
mer, cross-linker, and template ratios should be an important initial step 
in every MI protocol. Accordingly, this aspect has been receiving in-
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of MIPs with different polymerization mixture compositions and com-
pare their imprinting effectiveness to select the best combination for 
that particular application (36, 40, 44, 47, 82, 84, 90, 141, 153, 163). This 
methodology should also lead to the discovery and optimization of 
new formulations for MIP preparation, which is needed in this still 
developing field (99).
As an alternative, a more efficient high-throughput screening pro-
cedure has recently been developed for this type of empirical 
Table 2. Functional monomers used for epitope MI and corresponding intermolecular interactions.  
Functional monomer Molecular interaction(s) Reference(s)
Acrylic acid H-bonding; electrostatic (−) (42, 73, 77, 167–169)
Methacrylic acid H-bonding (67, 74, 76, 90, 93, 105, 106, 111, 140, 190, 224)
Methyl methacrylate H-bonding; hydrophobic (161, 223)
2-(Trifluoromethyl) acrylic acid Electrostatic (−) (90, 94, 96, 117, 140, 198)
2-(Hydroxyethyl) methacrylate Hydrophilic; H-bonding (90, 140, 142, 224)
2-(Aminoethyl) methacrylate H-bonding; electrostatic (+)
Benzyl methacrylate Hydrophobic; - stacking; aromatic rings may aid 
charge transfer
(109, 112)
3-Sulfopropyl methacrylate potassium Electrostatic (−); sulfur may aid grafting on gold 
surface
(109, 112)
Dimethylaminoethyl methacrylate Electrostatic (+) (90, 96, 140)
Acrylamide H-bonding (48, 67, 71, 92, 94, 95, 160, 171, 190, 199, 224)
Methacrylamide Hydrophilic; H-bonding (86, 90, 106, 157)
2-(Hydroxyethyl) acrylamide Hydrophilic; H-bonding (69)
Phenylacrylamide H-bonding; hydrophobic; - stacking (117)
N-tert-butylacrylamide Hydrophobic (73, 77, 90, 93, 96, 117, 167–169, 190, 198, 199, 224)
N-[3-(dimethylamino)propyl]methacrylamide Electrostatic (+) (42)
N-(3-aminopropyl)methacrylamide Electrostatic (+) (73, 77, 167, 169)
N-(2-aminoethyl)methacrylamide Electrostatic (+) (90, 140, 141, 225)




Electrostatic (+) (69, 157, 159)
N-acrylamido-benzamidine Electrostatic (+) (86)
N-methacryloyl-l-aspartic acid Electrostatic (−) (142)
Zinc acrylate Metal chelation; heterocyclic compound 
formation
(81, 82, 97, 102, 154, 170, 171)
Vinylphosphonic acid-Ti4+ Metal coordination (156)
Ti4+-ethylene glycol methacrylate phosphate Metal coordination; hydrophilic (153)
Vinylphenylboronic acid Hydrophobic; - stacking; boronate affinity for 
cis-diols
(85, 160, 161, 170)
4-Formylphenylboronic acid - stacking; boronate affinity for cis-diols (84)
3-Aminobenzeneboronic acid Electrostatic (+); - stacking; boronate affinity for 
cis-diols
(83)
3-Ureidopropyltriethoxysilane H-bonding; electrostatic (+) (70, 155, 172)
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selection process, allowing a simultaneous evaluation of 32 different 
monomer compositions in triplicate (162). This method combines 
the advantages of using small sample volumes in a 96-well filtration 
microplate with the reusability and affinity separation offered by 
solid-phase synthesis. In this ingenious approach, the template is 
covalently attached to a solid-phase support and placed in the micro-
plate wells, with each well containing a unique combination of 
monomers and cross-linker. After polymerization, weak-affinity 
MINPs are washed away, while high-affinity MINPs remain bound 
to the template in the wells. The larger the number of MINPs that 
remain in each well, the more adequate the composition of the cor-
responding polymerization mixture. In addition, by incorporating a 
fluorescent reporter monomer in the mix, the results can easily and 
quickly be acquired using a microplate fluorescence reader. The re-
sults of this assay were consistent with SPR affinity analysis, producing 
MINPs with KD in the nanomolar range, the usual benchmark for 
natural antibodies. These promising results suggest that case-by-case 
refinement of polymer composition can soon become an efficient 
routine step in MI works, contributing to increasing performances 
at decreased development costs.
Incorporation of computational modeling approaches
Notwithstanding its importance, the process of optimizing the 
polymer formulation is generally cumbersome. To make this pro-
cess more efficient, reducing expenditures in materials and reagents, 
several groups have taken advantage of software tools to model the 
molecular interactions between monomers, cross-linkers, and tem-
plates (176–182). These can be based on various computational ap-
proaches, including quantum chemical calculation (QCC), molecular 
mechanics (MM)/molecular dynamics (MD), and thermodynamic 
analysis (183, 184). Each approach is based on different assumptions 
and favors the assessment of different parameters.
QCC, traditionally the most commonly used method, is also the 
most precise in describing the interactions between smaller templates 
and functional sites of monomers. It works on the basis of quantum 
mechanics, making calculations based on electron orbitals or bands 
at the single-atom level. Its main aim is to solve Eq. 5, minimizing 
the association energy E
  E =  E C − ( E T + ∑ E M ) (5)
where E refers to Gibbs free energy, EC being that of the monomer- 
template complex, ET that of the template, and EM that of the isolated 
monomer(s) (93, 183, 185). However, the high level of detail of these 
models requires a correspondingly high computational power. This 
drawback restricts the use of QCC to small molecules and few at a 
time. Moreover, it does not consider the effects of solvent, time, and 
temperature (184, 186).
MM, on the other hand, sacrifices precision in predicting molec-
ular structure and binding energy to simplify calculations, making 
them more efficient and practical, especially for modeling multiple 
components. It is based instead on force fields, following Eq. 6
  E =  E 1,2 +  E 1,3 +  E 1,4 +  E VdW +  E el + … (6)
with E1,2 corresponding to bond stretching, E1,3 to bond angle bend-
ing, E1,4 to torsion of dihedral bond angle, EVdW to van der Waals 
interactions, and Eel to electrostatic interactions, with the possibility 
of adding additional terms corresponding to other interactions like 
H-bonds. The efficiency of these calculations allows a faster analysis 
of a greater number of elements. Furthermore, it can be combined 
with (i) the Newtonian laws of motion to include the time factor, 
(ii) Maxwell-Boltzmann distribution for analysis at different tem-
peratures, and (iii) restriction to a “box” of specified dimensions to 
control the pressure. These combinations of MM with additional 
parameters are termed MD. In addition, MM/MD simulations can 
also be applied for interaction between the template and the final 
polymer, which can provide different outcomes than those ob-
served for template/monomer complexes (184, 186). These proper-
ties have recently prompted an increase in the use of MM/MD 
compared to QCC, particularly by using the LEAPFROG algorithm 
in the framework of the SYBYL software suite (Tripos Inc., St. Louis, 
MO, USA) (177, 178, 180–182, 187, 188). In addition, Busato et al. 
(179) have developed MIRATE, a freely accessible platform to support 
and guide the user through the whole process of designing MIPs. 
Softening the requirement of specific knowledge on molecular mod-
eling techniques while presenting a user-friendly interface, this 
gateway can make computational modeling tools more accessible to 
a wider audience, contributing to accelerate MIP development.
Despite their advantages, neither of the previous approaches 
considers mesoscopic effects, which are also important to deter-
mine MIP properties. To analyze these effects, coarse-grained and 
thermodynamic simulations have proven useful (184, 189). The first 
simplifies monomers into equal spheres, allowing the simulation of 
much larger complexes with much less computational power. 
Consequently, larger-scale properties can be studied in these models. 
Although not as often, other groups have studied the thermodynam-
ic properties of polymerizing systems, drawing important conclu-
sions on the influence of particle mobility, template size, initiator 
concentration, or phase separation effects (184). Similar to the 
epitope choice, using computational modeling tools to assist the 
prediction of the best functional monomer candidates is a wise 
strategy that can save resources and time in protocol optimization 
later on.
In summary, the importance of selecting the most adequate 
polymeric formulation is recognized more than ever before. As dis-
cussed, this process should take into account the target application 
as well as the specificities of the template molecule. By analyzing 
available libraries, a careful and rational selection can be undertaken. 
This can then be refined by in silico models, particularly for opti-
mizing the ratio of each component in the polymerization mixture. 
Combined with high-throughput testing and the development of 
novel, more functionally rich monomers, we can foresee a contin-
ued growth in the production efficiency of epitope MIP platforms.
IMPRINTING METHODS AND APPLICATIONS
After selecting the reagents—epitope template, functional mono-
mers, and cross-linker—the next step in MIP production is to select 
a suitable preparation method according to its intended final appli-
cation. MIPs are available in a variety of formats, such as monoliths, 
membranes, or NPs, showing tremendous versatility of employment. 
This section explores the main imprinting methodologies currently 
applied, making an effort to identify their strengths and weaknesses, 
the types of MIP that can be produced, and their corresponding 
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Bulk imprinting
The first works on the field started by following the most straight-
forward bulk imprinting method (68, 74, 102, 142, 154, 190). This 
consists in dissolving the template molecule with the functional 
monomer(s) and cross-linker(s), thoroughly mixing to homogenize, 
allowing the monomers to interact with the template, followed by 
triggering the polymerization process (adding an initiator or irradi-
ating with ultraviolet light, for example). This leads to the forma-
tion of a macroscale polymeric structure, which can then be ground 
into particles, if that is the desired final shape (Fig. 6A). This is the 
simplest method for MIP synthesis and has the advantages of in-
volving the smallest number of different reagents and equipment, 
while allowing production of a variety of structures such as cryogels 
(Fig. 6B) (142), monoliths (68, 74), or films (Fig. 6C) (102), besides 
ground microparticles/NPs (154, 190).
By using this technique, poly(2-hydroxyethyl methacrylate- co-
N-methacryloyl-l-aspartic acid) cryogels were prepared for IgG pu-
rification in chromatography (142). The choice for cryogels rested 
on their microporous structure (shown in Fig. 6B), which was in-
tended to compensate for the diffusion limitations of macromole-
cules in bulk MIPs. These presented a surface area of 34.2 m2 g−1, with 
an average pore diameter of 37.2 Å, reaching a Qmax of 75.1 mg of IgG/g 
of cryogel. In other studies, methacrylate-based micro–solid-phase ex-
traction monolithic columns were developed for sample enrichment in 
selected physiologically produced peptides, namely, cholecystokinin 
(74) and encephalin (68). Both columns, prepared with the same pro-
tocol but different tetrapeptides, could be used over 100 times in a 
reproducible manner, with the ability to extract over 90% of target mol-
ecule from simulated and real cerebrospinal fluid samples. On the 
other hand, their adsorption capacity is manifestly inferior when com-
pared, for example, with the surface imprinting approach of Tan et al. 
(93) (described further ahead) due to shortcomings associated with the 
diffusional limitation of macromolecules in bulk MIPs.
Since template molecules are randomly distributed in the prepo-
lymerization mixture, a large number of them end up trapped in the 
polymer matrix. This works well for small molecules, including 
peptides, but major difficulties arise when applied to biomacromol-
ecules, as previously stated. Their low rates of diffusion through 
polymer networks due to their large size (or even lack of accessibility 
depending on the mesh size) means that purification and rebinding 
are inherently more difficult. This effect is observed even if the re-
sulting monolith is ground and sieved into particulate (87, 191). 
Moreover, this grinding process is also inefficient, since it damages 
and destroys binding sites, reducing the rebinding properties of the 
resulting MINPs. Besides, ground particles are usually heteroge-
neous in shape and size, which is less than optimal for precision 
applications (192).
Surface imprinting
To overcome these limitations, the technique known as surface 
imprinting was developed (193–195) and quickly adapted for the 
imprinting of epitopes as well. In the first studies exploring this strategy, 
the authors ingeniously used crude products from solid- phase pep-
tide synthesis to produce what was then named “hierarchically” 
Fig. 6. Bulk molecular imprinting method and representative applications. (A) Bulk imprinting procedure; bulk MIPs can further be processed into microparticles/
nanoparticles by grinding and sieving (dashed arrow). (B) Scanning electron microscopy micrographs of imprinted (MIP C) and nonimprinted (NIP C) poly(2-hydroxyethyl 
methacrylate-co-N-methacryloyl-l-aspartic acid) cryogels for IgG purification. Reproduced with permission (74). Copyright 2015, Elsevier. (C) Atomic force microscopy 
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imprinted materials (52, 53). This technique involves the restriction 
of the imprinting process, and therefore MIP-target interactions, to 
a single interface. This decreases the amount of template re-
quired, while providing higher binding site accessibility, improved 
binding kinetics, response speed, and regeneration (47, 87, 192). 
To that end, template molecules are attached to a suitable support-
ing surface, which can either be sacrificial or permanent, and po-
lymerization occurs only in a thin layer. On the downside, this 
technique results in fewer recognition sites, which can lower the 
binding capacity or the sensitivity in sensor applications, for 
example, (87, 191). Nevertheless, some strategies have been pro-
posed to overcome these limitations, such as using NPs with large 
relative surface areas to increase binding capacity (93, 196), enzymatic 
amplification to improve sensor signals (83, 103), or dual- template 
imprinting for improvement in both parameters (97). Variations of 
surface imprinting have spawned since its introduction, with dif-
ferent support structures and immobilization strategies.
Thin-film coatings
A widely used variation of surface imprinting is the production of 
an imprinted film on gold sensors, usually for SPR or QCM-based 
applications (72, 89, 91, 98, 108, 111, 112). These analytical techniques 
allow a direct evaluation of the binding capability of the produced 
MIP, while also representing promising precursors of point- of-care 
screening devices. Two imprinting methodologies can be distin-
guished for this purpose. One consists in covering the sensor with a 
premix of the epitope template and functional monomers, followed 
by polymerization. This has been performed through processes based 
on free radical polymerization (98), self-polymerization of dopa-
mine (72, 108), and electropolymerization (103). The second vari-
ant consists of a two-step process: First, the template is organized by 
self-assembly on the gold surface via, for example, thiol chemistry 
(usually by using cysteine end-modified peptides); next, the mono-
mer mix is added and polymerization started (Fig. 7A). The first 
step is thought to promote a single orientation of all template mol-
ecules, potentially leading to more uniform and, therefore, more 
sensitive and selective imprinted cavities. Methacrylate-based radi-
cal polymerization (111, 112), solvent evaporation using EVALs 
(99, 104), and electropolymerization of o-phenylenediamine (197) 
or scopoletin (89, 91) have been successfully applied to produce 
MIP films following this procedure. Unfortunately, various studies 
fail to report on important parameters of MIP evaluation, making 
detailed comparisons between methodologies difficult. Some repre-
sentative applications of this technique include detection of HIV in 
urine samples (108), TnT in blood samples for real-time testing of 
heart injury (72), or NSE for early diagnosis of small cell lung cancer 
(91). Cysteine terminal modification and histidine insertion into pep-
tide epitopes have been recently compared as template immobilization 
strategies (91). The results show that a histidine inserted in the mid-
dle of the sequence for attachment to gold wire sensors led to an 
order of magnitude lower LOD and KD, higher IF, and more than 
double the selectivity as compared to other peptides (one from 
another surface-exposed portion of the same protein, and another 
with a similar -helical structure and terminal cysteines) and 
bovine albumin. These suggest that histidine might be a superior 
alternative to the more common cysteine end-modification of pep-
tides for gold surface tethering in imprinting protocols.
Another significant advance introduced in MIP-based sensing 
platforms has been the incorporation of enzymatic amplification 
of the electrochemical signal by horseradish peroxidase (HRP) 
catalysis (103). In this variant, an HRP-coupled template is preincu-
bated with the sensor before its application in sample analysis. 
Then, the target protein competes with the HRP peptide for binding 
to the MIP; the greater the target concentration, the more HRP pep-
tide will be displaced. Last, it is immersed in a hydroquinone– 
hydrogen peroxide solution that reacts with HRP, triggering an 
electric current proportional to the remaining HRP peptide bound to 
the sensor. This signal is therefore inversely proportional to the tar-
get protein concentration, allowing its indirect calculation. This 
approach managed to increase the sensitivity of imprinted sensors, 
attaining an LOD of 0.02 nM.
Other strategies of surface coating with MIPs include cellulose 
membranes for monoclonal antibody purification from complex 
mixtures [as previously mentioned (106)] or a bioactive interface 
for cell sheet harvesting (69). The latter (Fig. 7B) consisted of a 
quartz surface coated with a polymer imprinted with the peptide tag 
DDDGGDDD (a structurally symmetrical and carboxyl-rich pep-
tide designed as epitope for this work). The surface molecular- 
recognition sites could be used to bind a bioactive peptide featuring 
the epitope tag at one terminus and cell-adhesive peptide RGD at the 
other end. Because of the reversibility of the peptide binding to the 
MIP cavities, the biointerface exhibited dynamic RGD presentation 
and, subsequently, controllable cell-adhesive behavior.
Imprinting on NP surfaces
A different way to leverage surface imprinting is by building thin 
imprinted coating layers on NPs of different kinds. This allows one 
to take advantage of the inherent physicochemical properties of a 
specific particle in combination with the molecular recognition po-
tential of MI (Fig. 8A). For example, carbon nanotubes and iron oxide 
NPs can be used for their magnetic properties to bind and extract a 
specific constituent from complex samples (81, 82, 93, 97, 101). This 
property also facilitates the preparation procedure through the ap-
plication of an external magnetic field, leading to a quick and efficient 
separation of the NPs. This has been used to isolate angiotensins I 
and II, important molecules for the maintenance of blood pressure 
and general homeostasis, which have very low concentrations in 
human blood (≈20 pg ml−1) (93,  196). These superparamagnetic 
particles achieved high adsorption capacities (above 70 mg g−1) and 
high selectivity (IF ≈ 5) and could remove more than 90% of angio-
tensin from human plasma samples. Iron oxide NPs have also been 
used to build an immunosensor for ultrasensitive detection of HIV-1 
antibody, as an effort to reduce the time between HIV infection and 
diagnosis (83). In this study, the authors prepared IgG-imprinted 
NPs, which were able to bind anti–HIV-1 antibody. By using en-
zymatic amplification [as described above (103)], the resulting 
sensors achieved a detection limit 200 times lower than existing 
ELISA assays.
SNPs are another type of particles that are especially interesting 
for surface imprinting, because their surface can easily be modified 
with silane derivatives, making them a versatile platform for surface 
functionalization. Moreover, as previously mentioned, SNPs are rel-
atively bioinert and transparent. Thus, they have attracted attention 
for use in sensing applications, by coupling a silica matrix with small-
er QDs, which emit fluorescent light in a specific controllable wave-
length (75,  155). These QD/SiO2/MIPNPs are then able to act as 
sensors that specifically recognize the target molecule thanks to the 
imprinted cavities in the polymeric shell. At the same time, thanks to 
the transparency of the SiO2 matrix, the QDs are still able to absorb 
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These systems have also been applied specifically with carbon dots, 
yielding MINPs with an LOD in the nanomolar range and the ability 
to work in complex samples, such as diluted urine (76).
A recent innovation that has been coupled with both magnetic 
and silica NPs is dual-template imprinting. By using two different 
template molecules simultaneously in the imprinting process, recent 
studies were able to either (i) increase the sensitivity and selectivity of 
MIP-coated carbon nanotubes (Fig. 8, B to E) to target albumin, us-
ing two epitopes form the same protein (97), or (ii) recognize two 
separate targets (albumin and transferrin) with the same nanotube 
formulation, using a single template from each (81).
This strategy has proven useful for targeted drug delivery 
(198, 199). Using the dual-template approach, poly-dopamine–
coated SNPs were imprinted with a conformational epitope of 
HER2, an overexpressed surface receptor in some cancer cells, and 
doxorubicin, a widely used chemotherapeutic drug (118). These 
NPs led to significantly increased doxorubicin concentration in 
tumor tissues, while slightly reducing its distribution in liver, kidney, 
and heart. They also led to over 70% cumulative survival, as com-
pared to approximately 30% for free doxorubicin or doxorubicin- 
NIP groups and zero for untreated controls. Similarly, zinc acrylate 
and vinylphenylboronic acid were used to coat SNPs with a MIP 
layer against bleomycin, another common anticancer drug, and the 
71-80 peptide of human fibroblast growth factor–inducible 14 
(Fn14) modified with glucose, to target a specific type of pancreatic 
cancer cells (170). In vitro imaging showed specific targeting of 
Fn14-overexpressing cells, while in vivo administration of bleomycin- 
loaded MINPs inhibited xenografted tumor growth [1.05× increase 
in size, compared to 1.5× for free bleomycin and 1.6× for bleomycin- 
loaded nonimprinted NPs (NINPs)].
Polymeric NP imprinting
MINPs can also be prepared to be fully polymer-based. Two different 
methods have been mainly used in these strategies. One is 
precipitation polymerization, which happens in aqueous media 
and uses organic solvents for the subsequent NP precipitation 
(94, 153, 156). The second is inverse microemulsion polymerization 
(130). In this technique, a dispersed aqueous phase containing the 
functional monomers and a continuous organic phase containing 
surfactants are mixed to form an emulsion. For enameling the im-
printing template, it must be modified with a hydrocarbon tail to 
become amphiphilic, thus positioning itself at the interface of the 
inverted micelles. Unlike in the former method, this ensures that 
the template remains at the surface of the forming MINPs after ini-
tiating polymerization in the aqueous phase (Fig. 9A) (48, 71). It 
can therefore be considered a particular case of surface imprinting. 
Fig. 7. Surface imprinting on thin flat films. (A) Surface MI procedure, allowing the creation of surface-accessible binding sites for the target molecule. (B) Generation 
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This technique also allows a relatively precise control over particle 
diameter, yielding NP populations with a low polydispersity index.
Adopting this strategy, polymeric MINPs were developed to 
bind Lpp20, an outer membrane protein of Helicobacter pylori, a 
bacterium that has been linked to stomach cancer (92). These were 
able to bind significantly more bacteria than NINPs and NPs im-
printed with the unmodified epitope (without the hydrophobic tail), 
constituting a promising first step for the development of a poten-
tial future bactericidal therapy. Following this synthesis concept, 
another study designed an innovative targeted drug delivery system, 
by imprinting NPs with a palmitic acid–modified conformational 
epitope of cancer biomarker p32 (71). These MINPs could be loaded 
with the drug methylene blue during the preparation process, 
demonstrated the ability to localize to tumor tissues, and signifi-
cantly inhibited their growth in mice models (Fig. 9B), while being 
biocompatible with healthy tissues. As previously mentioned, 
this imprinting strategy has also been recently used to produce 
polyacrylamide-based MINPs against TGF-3 (48). These MINPs 
were then applied as receptors in adipose tissue–derived stem cell 
(ASC) culture substrates to sequester endogenously produced 
TGF-3 (Fig. 9C). ASCs in 2D cultures showed a marked up-regulation 
of SOX-9 (a downstream target of TGF-3 signaling), while in 3D 
cultures, there was an increased deposition of collagen II–rich matrix 
(Fig. 9D). These outcomes suggest that MINPs could direct stem 
cell commitment without exogenous growth factor supplementation, 
thus constituting cheap, stable alternative growth factor receptors 
for tissue engineering applications.
Polymeric NPs can also be coupled with fluorescent QDs for 
tracking and quantification assays, as previously mentioned for silica- 
based systems (76, 88, 95). These have been used, for example, to 
quantify albumin in human serum samples (88), or for cell imaging, 
by targeting specific glycosylation sites (157). In the latter work, two 
types of fluorescent core-shell particles were prepared: glucuronic 
acid–imprinted NPs coupled with green QDs and N-acetylneuraminic 
acid–imprinted NPs coupled with red QDs. This allowed simultane-
ous recognition of HA and sialylated glycoproteins/glycolipids on 
keratinocytes. These results helped to demonstrate the applicability 
of MIPs for saccharide recognition, a fast-expanding research field 
with increasingly recognized impact in human health and biomedicine 
(200). In this context, these MINPs might contribute to the emergence 
of new diagnostic tools, since aberrant glycosylation is known to 
occur in disease conditions such as several cancer phenotypes (201).
Another relatively recent addition to the MINP toolbox has been 
reported by the Zhao group (202, 203) and consists of a MI process 
in micelles. This creative method is based on the use of a novel 
cross-linkable surfactant monomer that self-assembles into mixed 
micelles, where the template imprinting takes place. A first round of 
cross-linking of azide groups yields surface–cross-linked micelles. 
These can be surface-functionalized in a second click reaction with 
hydroxyl-rich monomers to ensure that MINPs are highly soluble 
in water and to facilitate their separation. Last, the micellar core, 
which encompasses a vinyl-based cross-linker and other vinyl- 
containing functional monomers (for example, to incorporate elec-
trostatic interactions with charged amino acids), is photocrosslinked. 
This carefully designed supramolecular construction allows the 
production of MINPs with sizes close to natural receptors (∼5 nm) 
that can precisely discriminate between closely related small pep-
tides (204, 205) and, as recently demonstrated, also glycans (39, 40). 
This ability has been leveraged to achieve impressive biologically 
relevant results in sequence-selective protection of larger peptides 
(angiotensins, amyloid-) from proteolysis (206), selective phos-
phorylation of peptides and proteins (207), and synthetic hydrolysis 
of oligo- and polysaccharides (such as cellulose) (208, 209). Although 
the synthesis of MINPs and its precursors involves nontrivial la-
borious processes, this is a versatile one-pot method that results 
in extraordinary templating effects for a variety of different biomol-
ecule epitopes. Thus, we foresee exciting developments in the appli-
cation of this system in the near future.
Solid-phase imprinting
Several MI studies have been adopting a recently introduced inno-
vative method of MINP synthesis, developed in parallel by two groups 
from the University of Leicester (UK) and Compiègne University of 
Technology (France), termed solid-phase imprinting (24, 210, 211). 
In this technique, the template molecule is tethered to the surface of 
a solid-phase support (originally, glass microbeads). The function-
alized supports are then immersed in a liquid phase containing the 
prepolymer mixture, of which NIPAAm is a main component to 
confer thermoresponsiveness to the polymer. At this point, the 
monomers in solution reorganize around the immobilized template 
Fig. 8. Surface imprinting on NP thin coatings. (A) MI procedure with immobi-
lized templates on the surface of an NP. (B to E) Transmission electron microscopy 
images of (B) magnetic carbon nanotubes (MCNTs), (C) silica-coated MCNTs, (D) 
MCNTs coated with methacryloxypropyl trimethoxysilane, and (E) MIP-coated 
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through noncovalent interactions. After starting the polymerization 
process in the liquid phase, an array of polymeric NPs with different 
affinities and sizes are formed in suspension.
In the protocol proposed by the Piletsky group, the mixture is 
then washed several times at or below room temperature to remove 
weakly bound NPs, which did not form suitable binding sites. When 
this process is complete, only the particles with a strong affinity for 
the template remain bound to the solid phase. These are the NPs 
that were formed by the monomers directly interacting with the im-
mobilized template, acquiring full-fledged imprinted cavities. They 
are then recovered by eluting with hot water, with enough energy to 
disrupt those bonds. This is eased by poly-NIPAAm’s thermore-
sponsive behavior, transitioning from its swollen hydrophilic to its 
shrunken hydrophobic state above 32°C, thereby changing its spa-
tial arrangement and detaching from the template molecules. This 
procedure is illustrated in Fig. 10A. On the other hand, works 
performed by Bui and Haupt’s group (159, 212) have presented a 
variation of this step, where the polymerization and affinity purifi-
cation temperatures are switched. In this instance, polymerization 
occurs above 32°C (in collapsed state), and high-affinity MINPs are 
eluted below this temperature (in their swollen form). The ra-
tionale behind this choice is that when these MINPs are used in 
physiological conditions (37°C), they will be in the same collapsed 
state in which they were imprinted, thus ensuring that the confor-
mation of their binding sites is adequate for target binding. Despite 
the sound logic of this hypothesis and the results achieved in these 
studies, the fact remains that MINPs produced at room temperature 
also performed successfully in vivo (73, 169). Future studies com-
paring both variations could further elucidate this question.
Solid-phase imprinting holds several advantages over tradition-
al MI protocols. First, removal of the template and isolation of 
MINPs is easier and straightforward. Second, since the template is 
Fig. 9. Inverse microemulsion MI and representative applications. (A) Scheme depicting the process of surface imprinting of polymeric NPs by inverse microemulsion 
polymerization. (B) MINPs against cancer biomarker p32, carrying the chemotherapeutic drug methylene blue, tendentially accumulated in tumoral tissues and drastical-
ly reduced tumor growth in mice. Adapted with permission (71). Copyright 2015, Wiley. (C) Tissue culture plastic coverslips coated with MINPs (but not NINPs) can seques-
ter and retain target transforming growth factor–3 (TGF-3). Left: AFM images of coated coverslips. Right: fluorescent immunolabeling of TGF-3. Scale bars, 250 nm 
(left), 100 m (right). (D) ASC cell pellets cultured with MINPs (left) grew to larger sizes and produced more collagenous matrix than pellets cultured with NINPs (right). 
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immobilized at the solid phase, not only is it not lost during purifi-
cation but it is also entirely reusable for multiple synthesis cycles, a 
possibility that is especially attractive for more expensive template 
molecules. Third, the two-step elution purification process results in 
the recovery of a more uniform suspension, with similar high-affinity 
NPs, reminiscent of monoclonal antibodies. Last, it can be scaled up 
and adapted into a continuous reactor, holding great promise for 
upscaling in industrial production (213).
Solid-phase imprinting using epitope templates and acrylamide- 
derived monomers polymerized under mild conditions in PBS has 
been applied to generate NPs capable of recognizing several distinct 
human macromolecules (73, 77, 159, 167, 169). For example, MINPs 
coupled with QDs were produced to recognize human VEGF, 
achieving a KD of 1.78 nM. When injected in zebrafish models, these 
NPs were able to successfully accumulate in tumors overexpressing 
this growth factor, while in a human VEGF–negative model, this 
ability was completely lost (73). A similar approach was followed to 
imprint NPs with an epitope of epidermal growth factor receptor 
(EGFR) (77, 167). In a first study, these MINPs contained a fluorescent 
monomer, N-fluoresceinyl acrylamide, and were able to localize to 
the cytoplasm of cells with high EGFR expression but not to cells 
without the receptor (Fig. 10B). Incorporating fluorescent mono-
mers in the composition of MINPs is an interesting alternative to 
the encapsulation of QDs for targeted imaging or drug delivery ap-
plications, because it simplifies the preparation procedures while 
avoiding the employment of potentially toxic components (QDs 
can leak heavy metals into the body, as discussed before) (159, 169). 
In a subsequent study, EGFR-MINPs produced by applying the 
double-template imprinting approach could be loaded with doxo-
rubicin, augmenting the efficacy of the drug 1.5 times compared to 
Fig. 10. Solid phase imprinting method. (A) Solid-phase epitope imprinting procedure. The affinity purification steps allow removal of low-affinity particles and unre-
acted monomers by eluting at the same temperature as polymerization (blue arrow), followed by recovery of high-affinity MINPs at a different temperature (red arrow). 
(B) Confocal microscopy images of cancer cell line cultures with low (left) and high (right) expression of epidermal growth factor receptor (EGFR). MINPs against EGFR 
(green) accumulate significantly only in cells with high expression. Adapted with permission (77). Copyright 2018, American Chemical Society. (C) MINPs against 2 mi-
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its administration in free form. The drug’s cytotoxic effects were 
shown to be restricted to EGFR-expressing cells (77).
Adopting this concept, other groups have developed fluores-
cent MINPs targeting 2 microglobulin (B2M), an extracellular 
component of major histocompatibility complex class I (169). 
Since these proteins are overexpressed in senescent cells, B2M-
MINPs could efficiently target them, staining up to 90.3% of 
target cells compared to 9.7% of control cells. When injected intra-
venously in mice, they accumulated in older specimens (11 months 
old), while in young ones (2 months old), no fluorescence was 
observed 2 hours after the treatment (Fig. 10C). In another work, 
solid-phase imprinting was used to prepare MINPs tagged with 
rhodamine B for specific visualization of HA (159). With their 
relatively small sizes (~70 nm), they were capable of staining in-
tracellular HA, unlike previous MINPs produced by precipitation 
polymerization.
Last, an innovative cancer therapy was demonstrated based on 
MINPs targeting the common N-terminal sequence of E-, R-, and 
N-cadherins (212). These membrane proteins are responsible for 
cell-cell adhesion, constituting an essential mechanism in tumor re-
sistance to drugs, as well as metastasis. Since these MINPs targeted 
the protein site directly responsible for adhesion, they were able to 
inhibit HeLa cell aggregation, disrupt preformed tumor spheroids, 
and even inhibit cancer cell invasiveness in vitro.
In summary, this production method has quickly asserted itself 
as an efficient way to realize the promise of artificial antibodies for 
biomolecules. Since its introduction, it has quickly shown its po-
tential for targeted drug delivery, bioimaging, and biosensing. It 
has consistently attained subnanomolar KD values, comparable to 
monoclonal antibodies, which, along with its reproducibility and 
scalability, make it very attractive for macromolecule targeting. Its 
main downside thus far seems to be the relatively low production 
yield per batch, between 0.2 and 0.6 mg/g of glass beads (24, 35). 
A possible solution could be to use solid-phase supports with smaller 
diameters, in particular, magnetic microparticles/NPs (214). These 
types of supports present a greatly increased surface area, thus 
allowing a higher template density and, consequently, production 
of larger amounts of MINPs. Furthermore, glass beads should not 
be stirred during synthesis steps owing to the possibility of surface 
abrasion and loss of immobilized template. This makes the pro-
cess good for continuous solvent percolation in large flow reac-
tors, but less than ideal for small batch reactors. Well-dispersed 
magnetic NPs minimize this hurdle and can be easily washed and 
separated from solution by magnetic sorting, being thus more 
versatile. This protocol has recently been expanded to protein 
imprinting with promising results (35, 215), setting high expecta-
tions for future developments in epitope imprinting applying similar 
systems.
CONCLUSIONS AND PERSPECTIVES
MI has come a long way since its inception, becoming a standard 
technique for application-oriented research in small-molecule rec-
ognition, with commercial MI products being available today (216). 
Its use in the biological field, however, has historically been ham-
pered by a variety of drawbacks. Despite its relatively recent 
introduction, the epitope approach has quickly gained traction over 
the past decade, thanks to its attractive advantages helping to over-
come the limitations typically associated with imprinting of 
entire macromolecules in polymeric materials. Its considerably 
more versatile and economic production makes this approach par-
ticularly interesting for the imprinting of biologically relevant mol-
ecules. In this context, the completely synthetic nature of MIPs is 
especially relevant in an era where ethical, political, and financial 
concerns regarding animal use increasingly take center stage (13). 
Along with their potential low cost, scalability, and long-term sta-
bility, they present an elegant alternative to biological recognition 
molecules like antibodies (12).
Nonetheless, as an emerging strategy, it too faces a number of 
challenges to realize its potential. For example, the parameters 
analyzed in each study to describe MIP performance differ greatly 
between them, making comparisons difficult. Harmonizing and 
adopting standardized testing methods could greatly improve re-
search progress (78, 80). Considering the choice of molecular tar-
gets, it is interesting to notice that researchers have only recently 
begun to introduce complexity into the process and expand to more 
than proof-of-concept experiments. For years, the important devel-
opments of different MI protocols have dominated research focus 
in this field. Logically, for optimization purposes, the preferential 
molecular targets remained restricted to affordable proteins that do 
not provide much of a practical use. However, thanks to the re-
markable progress made on synthesis methods, epitope imprinting 
is expanding to more valuable targets, such as cell surface biomarkers 
or growth factors. In parallel, the increasingly sought bioinformatic 
tools allow a more detailed screening of protein structures, thereby 
improving the epitope selection. Together, this means that more 
applications can be envisioned (217), such as targeted drug delivery 
(25, 77, 171), theranostics (218, 219), or tissue engineering (12, 48, 220). 
Progressively, the use of molecular modeling platforms is also mak-
ing MIP development faster and more efficient, lowering the time 
and resources necessary for optimizing the polymer composition. 
These steady advances, along with the appearance of new compa-
nies based on this technology (e.g., MIP Diagnostics Ltd., Semorex), 
show that we can confidently expect MIPs to become true “plastic 
antibodies” and serve as far-reaching tools in biomedicine in the 
not-too-distant future.
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